The Harvard Drug Group is recalling approximately 17,586 cartons of Major Pharmaceuticals brand Carbidopa and Levodopa tablets (25 mg/100 mg). This recall was initiated because some blister packaging was not properly sealed, which could compromise the medication. If you use this medication, contact your healthcare provider or pharmacist for guidance.
An inadequate seal on the blister pack can expose the tablets to moisture and air, potentially reducing the drug's effectiveness or causing it to degrade before its expiration date. No injuries or adverse events have been reported to date.
You have 2 options:
Manufactured in Czech Republic by Teva Czech Industries for Teva Pharmaceuticals USA. Packaged and Distributed by Major Pharmaceuticals.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.